Adage Capital Partners Gp, L.L.C. Seagen Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $8.5 Million - $9.6 Million	-44,389 Reduced 20.1%	176,404 $37.4 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $33.6 Million - $37 Million	-179,207 Reduced 44.8%	220,793 $42.5 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $51 Million - $81.2 Million	400,000 New	400,000 $81 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $32 Million - $52.7 Million	294,130 New	294,130 $52 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.